T-Cell Prolymphocytic Leukemia
Alemtuzumab Successful In Clinical Trial
Published in Cancer Weekly, November 6th, 2001
The new data strongly indicate that Campath can be effective as first-line therapy for T-PLL, which would represent another step forward in Schering's strategy to strengthen its role in different indications in the field of hematological oncology.
Campath was approved in the U.S. and Europe (trade name in Europe: MabCampath) earlier this year (2001) and is currently available to patients with B-cell chronic lymphocytic leukemia (B-CLL), who have been...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2001-11-06)
More Articles from Cancer Weekly
- Non-Hodgkin Lymphoma
Similar Efficacy In Stem Cell Graft Induction Regimens With Or Without Radiation - Skin Cancer
Tumor Vaccine Causes Regression, Reduces Metastasis In Incurable Melanoma - Breast Surgery
Acupuncture Is As Effective As Drugs For Pain, Nausea - Epidemiology
Researchers To Study Why Blacks Get, Die More From Cancer - Ovarian Cancer
Researchers Seek To Develop Test For Women's Deadliest Cancer - Risk Factors
Animal-Based Nutrients Linked With Higher Risk Of Stomach, Esophageal Cancers - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
